Eric D. Shaff, CFO and EVP at Seres Therapeutics, Inc. (MCRB), sold 5,001 shares at $28.85 ($141K) on 2016-06-28, disclosed to the SEC on 2016-06-29.
Scheduled sale ($141k) by CFO and EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 3,334 | $93K | 66.0% |
| 2 | $28.85 | 1,667 | $48K | 34.0% |
| Total | $28.28 avg | 5,001 | $141K | 100% |
| Filing → |
| MCRB | SELL | 2026-02-18 | $2K | — | Filing → |
| MCRB | SELL | 2025-11-18 | $4K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $4K | — | Filing → |